Editor's Note Significant progress has been made in national health efforts to prompt women to look for signs of breast cancer earlier and inform them about their breast cancer risk, but continued efforts are needed, Chief Healthcare Executive October 30 reports. Among women younger than 50, breast cancer is the…
Editor's Note A large study led by researchers at McMaster University in Ontario, Canada, identified 10 predictors of opioid overdose after prescription for chronic pain, as published by CMAJ (Canadian Medical Association Journal) on October 23. While there are screening tools to identify patients at higher risk of addiction or…
Editor's note According to a research letter, titled “Use of metabolic and bariatric surgery among US youth” and published by JAMA Pediatrics on May 30, “more young people between the ages of 10 and 19 are undergoing weight-loss surgeries,” Chief Healthcare Executive June 1 reports. This emerging trend has prompted…
Editor's Note Because there is limited data to guide return to driving recommendations for patients after surgery, researchers at the Massachusetts General Hospital, Boston, performed this nested case-crossover study to find if the risk of a motor vehicle crash increases after surgery, compared to before. The analysis included 70,722 licensed…
Editor's Note New research from the American College of Surgeons and American Cancer Society describes ways the National Cancer Database (NCDB) was impacted by the COVID-19 pandemic. For the study, researchers reviewed 4,045,097 cancer cases of adults 18 years or older who were diagnosed with cancer and/or received their first-course…
Editor's Note The Food and Drug Administration (FDA) on March 31 identified the recall by Datascope/Getinge of certain Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pumps (IABPs) for risk of unexpected shutdown after PCBA communication loss as Class I, the most serious. On March 17, the FDA also identified Datascope/Getinge’s recall…
Editor's Note The American Society of Anesthesiologists (ASA), on March 29, issued a news report urging the public to learn to recognize and respond to an opioid overdose, now that the Food and Drug Administration has approved naloxone for sale over the counter. Naloxone, which is commonly sold as a…
Editor's Note New safety considerations for using validated suicide risk screening tools related to implementation and training were released by The Joint Commission on March 27. When working with patients at risk of suicide, screening tools can help determine appropriate treatment options and whether further assessment is needed. However, it…
Editor's Note This study by researchers from Veteran Affairs Boston finds that recent COVID-19 infection was not associated with risk of postoperative outcomes, regardless of timing within the previous 60 days. A total of 29,093 patients who had surgery at 123 hospitals were included in the analysis. Of 15,553 surgical…
Editor's Note The Food and Drug Administration (FDA), on March 8, issued an update on reports of squamous cell carcinoma in the scar tissue (capsule) that forms around breast implants—both saline and silicone as well as textured and smooth. Previously, on September 8, 2022, the FDA informed the public of…